General: In patients suspected of intracranial hemorrhage, administration of Vertisin should be initiated from 10 days to 2 weeks after the attack where hemostasis has been estimated to be established.
Use in pregnancy: In animal studies (rats and mice), the incidence of cleft palate has been reported. Use of cinnarizine should be avoided in pregnant women or women of childbearing potential.
Other Services
Country
Account